Showing results (231-240 of 377) with videos related to

Sort By:
Pageof 38
Clinical Endoscopy|October 28, 2021
Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort studyKoh Kitagawa, Akira Mitoro, Takahiro Ozutsumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 5, 2022
Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification testAtsushi Hiraoka, Masato Nakai, Nagisa Hara, et al.
Journal of Gastroenterology and Hepatology|August 7, 2019
Effect of furosemide on muscle cramps in patients with liver cirrhosisYasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, et al.
Alcoholism, Clinical and Experimental Research|December 31, 2005
Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitisMasahito Uemura, Tomomi Matsuyama, Masatoshi Ishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 28, 2023
Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis BMisako Tanaka, Takemi Akahane, Hideto Kawaratani, et al.
Medicine|July 16, 2019
A pancreatic mucinous cystic neoplasm undergoing intriguing morphological changes over time and associated with recurrent pancreatitis: A case reportErika Shioyama, Akira Mitoro, Hiroyuki Ogawa, et al.
Anticancer Research|October 26, 2022
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective StudySoichi Takeda, Tadashi Namisaki, Yuki Tsuji, et al.
Cancers|May 11, 2024
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular CarcinomaTetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, et al.
Journal of Hepatology|June 9, 2009
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinomaHitoshi Yoshiji, Ryuichi Noguchi, Masahisa Toyohara, et al.
World Journal of Gastrointestinal Oncology|October 31, 2019
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patientsHiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, et al.
Pageof 38